SEARCH

SEARCH BY CITATION

References

  • 1
    Lichtenstein L, Ishizaka K, Norman P, Sobotka A, Hill B. IgE antibody measurements in ragweed hay fever: relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973;52:472482.
  • 2
    Norman P, Lichtenstein L, Ishizaka K. Diagnostic tests in ragweed hay fever. J Allergy Clin Immunol 1973;52:210224.
  • 3
    Freidhoff L, Marsh D, Meyers D, Hussain R. The structuring of an allergy index based on IgE-mediated skin sensitivity to common environmental allergens. J Allergy Clin Immunol 1983;72:274287.
  • 4
    Nickelsen J, Georgitis J, Reisman R. Lack of correlation between titers of serum allergen-specific IgE and symptoms in untreated patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1986;77:4348.
  • 5
    Somville M, Machiels J, Gilles J, Saint-Remy J. Seasonal variation in specific IgE antibodies of grass-pollen hypersensitive patients depends on the steady state IgE concentration and is not related to clinical symptoms. J Allergy Clin Immunol 1989;83:486494.
  • 6
    Di Gioacchino M, Cavallucci E, Di Stefano F, Verna N, Ramondo S, Ciuffreda S et al. Influence of total IgE and seasonal increase of eosinophil cationic protein on bronchial hyperreactivity in asthmatic grass-sensitized farmers. Allergy 2000;55:10301034.
  • 7
    Wickman M, Ahlstedt S, Lilja G, Hamsten M. Quantification of IgE antibodies simplifies the classification of allergic diseases in 4-year old children: a report from a birth cohort study-BAMSE. Pediatr Allergy Immunol 2003;4:441447.
  • 8
    Wickman M, Lilja G, Soederstroem L, Van Hage Hamsten M, Ahlstedt S. Quantitative analysis of IgE antibodies to food and inhalant allergens in 4-year-old children reflects their likelihood of allergic disease. Allergy 2005;60:650657.
  • 9
    Simpson A, Soderstrom L, Ahlstedt S, Murray S, Woodcock A, Custovic A. IgE antibody quantification and the probability of wheeze in preschool children. Allergy 2005;116:744749.
  • 10
    Illi S, Von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006;368:763770.
  • 11
    Kuehr J, Brauburger J, Zielen S, Schauer U, Kamin W, Berg A et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002;109:274280.
  • 12
    MacGlashan D, Bochner B, Adelman D, Jardieu P, Togias A, McKenzie-White J et al. Down-regulation of FceRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:14381445.
  • 13
    Prussin C, Griffith D, Boesel K, Lin H, Foster B, Casale T. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol 2003;112:11471154.
  • 14
    Lin H, Boesel K, Griffith D, Prussin C, Foster B, Romero F et al. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils. J Allergy Clin Immunol 2004;113:297302.
  • 15
    Milgrom H, Fick R, Su J, Reimann J, Bush R, Watrous M et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999;341:19661973.
  • 16
    Solèr M, Matz J, Townley R, Buhl R, O’Brien J, Fox H et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18:154161.
  • 17
    Busse W, Corren J, Lanier B, McAlary M, Fowler-Taylor A, Della Cioppa G et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184190.
  • 18
    Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M et al. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 2001;108:E36.
  • 19
    Ädelroth E, Rak MS, Haahtela T, Aasand G, Rosenhall L, Zetterstrom O et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000;106:253259.
  • 20
    Casale T, Condemi J, LaForce C, Nayak A, Rowe M, Watrous M et al. Effect of Omalizumab on symptoms of seasonal allergic rhinitis. JAMA 2001;286:29562967.
  • 21
    Axen R, Drevin H, Kober A, Yman L. A new laboratory diagnostic system applied to allergy testing. N Engl Reg Allergy Proc 1988;9:503.
  • 22
    Casale T, Bernstein L, Busse W, LaForce C, Tinkelman T, Stoltz R et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110121.
  • 23
    Niggemann B, Rolinck-Werninghaus C, A M, Binder C, Ziegert M, Beyer K. Controlled oral food challenges in children – when indicated, when superfluous? Allergy 2005;60:865870.
  • 24
    Plewako H, Arvidsson M, Petruson K, Oancea I, Holmberg K, Ädelroth E et al. The effect of omalizumab on nasal allergic inflammation. J Allergy Clin Immunol 2002;110:6871.
  • 25
    Djukanovic R, Wilson S, Kraft M, Jarjour N, Steel M, Chung K et al. The effects of anti-IgE (Omalizumab) treatment on airways inflammation in allergic asthma. Am J Respir Crit Care Med 2004;170:583593.
  • 26
    Corren J, Diaz-Sanchez D, Saxon A, Deniz Y, Reimann J, Sinclair D et al. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis. Ann Allergy Asthma Immunol 2004;93:243248.
  • 27
    Burrows B, Martinez F, Halonen M, Barbee R, Cline M. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271277.
  • 28
    Sears M, Burrows B, Flannery E, Herbison G, Hewitt C, Holdaway M. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991;325:10671071.
  • 29
    Hamilton R. Accuracy of US Food and Drug Administration–cleared IgE antibody assays in the presence of anti-IgE (omalizumab). J Allergy Clin Immunol 2006;117:759766.
  • 30
    Nopp A, Johansson S, Ankerst J, Bylin G, Cardell L, Grönneberg R et al. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006;61:298302.
  • 31
    Walker S, Monteil M, Phelan K, Lasserson T, Walters E. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 2006. Art. No.: CD003559. DOI: DOI: 10.1002/14651858.CD003559.pub3.
  • 32
    Bousquet J, Wenzel S, Holgate S, Lumry W, Freeman P, Fox H. Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma. Chest 2004;125:13781386.